Osborne Partners Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4M | Buy |
|
|||||
|
2025
Q1 | $8.29M | Buy |
|
|||||
|
2024
Q4 | $8.91M | Buy |
|
|||||
|
2024
Q3 | $9.29M | Buy |
|
|||||
|
2024
Q2 | $8.61M | Buy |
|
|||||
|
2024
Q1 | $8.49M | Buy |
|
|||||
|
2023
Q4 | $7.88M | Buy |
|
|||||
|
2023
Q3 | $6.17M | Buy |
|
|||||
|
2023
Q2 | $6.94M | Buy |
|
|||||
|
2023
Q1 | $6.26M | Buy |
|
|||||
|
2022
Q4 | $6.69M | Sell |
|
|||||
|
2022
Q3 | $6.54M | Buy |
|
|||||
|
2022
Q2 | $5.86M | Buy |
|
|||||
|
2022
Q1 | $6.94M | Buy |
|